Molenzavir 200Mg - Anti-COVID Generic Drug Molnupiravir

Molenzavir 200Mg - Anti-COVID Generic Drug Molnupiravir

Enquiry Now


Description

Another milestone of INCEPTA: UK MHRA approved oral Anti Covid drug Molnupiravir with brand name #Molenzavir. We are proud to be in the service of the people.


Available to order

Mobile / WhatsApp : +44 7887 477007
Email : info@premiameds.com

#covid #people #brand #premiameds #premiabiotech

Additional Information

Molnupiravir is the world’s first oral pill to treat symptomatic COVID-19 which was approved by the UK’s Medicines and Healthcare products Regulatory Agency on 4 November 2021. Molnupiravir is originally developed by the US based pharma major Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics.


You May Also Like...

TESTIMONIALS